ταλέντο Στοιχειώδης Όρος Kilauea oral bile salt therapy ursodeoxycholic acid κίνηση το κόκκινο τρύπα
Frontiers | Research Progress of Bile Acids in Cancer
Developments in bile salt based therapies: A critical overview - ScienceDirect
Ursodiol for Hepatobiliary Disorders
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect
Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases? | American Journal of Physiology-Gastrointestinal and Liver Physiology
Pharmaceutics | Free Full-Text | Enhancing Dissolution and Oral Bioavailability of Ursodeoxycholic Acid with a Spray-Dried pH-Modified Extended Release Formulation
Changes in biliary lipid and biliary bile acid composition in patients after administration of ursodeoxycholic acid.
Therapy of gallstone disease: What it was, what it is, what it will be
PDF) Effective Treatment of Unconjugated Hyperbilirubinemia With Oral Bile Salts in Gunn Rats | Jaroslav Zelenka - Academia.edu
Serum Bile Acid Profiles Improve Clinical Prediction of Nonalcoholic Fatty Liver in T2DM patients | Journal of Proteome Research
The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models | Lipids in Health and Disease | Full Text
Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics
Amazon.com: Jarrow Formulas High Potency Bile Acid Factors Formula, Supports Digestion and Absorption of Fats & Fat-Soluble Nutrients, 30 Servings, White, Vanilla, 120 Count : Health & Household
Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study | Scientific Reports
The canadian multicenter doubleâ•'blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
GALLSTONE DISEASE Prof.Dr.Ahmet Dobrucalı İÜ.Cerrahpaşa Tıp Fakültesi - ppt download
Frontiers | Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
Newer Approaches to the Management of Pruritus in Cholestatic Liver Disease | SpringerLink
Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease. - Abstract - Europe PMC
Frontiers | Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin - Nano Market
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect
Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy | Scientific Reports
Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway | Molecular Pharmacology
Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels | American Journal of Physiology-Gastrointestinal and Liver Physiology